74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
STERIS PLC
Closed
Sector Healthcare
220.17 -0.19
Overview
Share price change
24h
Min
218.92
Max
220.32
Income | 16M 173M |
|---|---|
Sales | 42M 1.4B |
P/E Sector Avg | 35.593 73.394 |
EPS | 2.32 |
Dividend yield | 1.03 |
Profit margin | 12.643 |
Employees | 18,000 |
EBITDA | -85M 245M |
Recommendations | Buy |
|---|---|
12 Months Forecast | +20.15 upside |
Dividend yield Sector Avg | 1.03% 3.09% |
|---|---|
Next Earnings | 7 May 2025 |
Next Dividend date | 21 Mar 2025 |
Market Cap | 22B |
|---|---|
Previous open | 220.36 |
Previous close | 220.17 |
News Sentiment
By Acuity
34%
66%
92 / 393 Healthcare
Technical Score
By Trading Central
Confidence
Strong Bearish Evidence
STERIS PLC Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
STERIS PLC Forecast
Price Target
By TipRanks
20.15% upside
12 Months Forecast
Average 265 USD 20.15%
High 265 USD
Low 265 USD
Based on 3 Wall Street analysts offering 12 month price targets forSTERIS PLC - Dist in the last 3 months.
Sentiment
By Acuity
92 / 393 Healthcare
News Sentiment
Bullish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About STERIS PLC
STERIS plc provides infection prevention products and services worldwide. It operates through three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument, devices, and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The AST segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of contract sterilization and laboratory facilities, as well as integrated sterilization equipment and control systems to medical device manufacturers and research institutions. The Life Sciences segment designs, manufactures, and sells consumable products, such as pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. It serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is headquartered in Mentor, Ohio.
